These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11197335)

  • 21. Analogs of methyl-piperidinopyrazole (MPP): antiestrogens with estrogen receptor alpha selective activity.
    Zhou HB; Carlson KE; Stossi F; Katzenellenbogen BS; Katzenellenbogen JA
    Bioorg Med Chem Lett; 2009 Jan; 19(1):108-10. PubMed ID: 19014882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.
    Meyers MJ; Sun J; Carlson KE; Marriner GA; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2001 Nov; 44(24):4230-51. PubMed ID: 11708925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acyclic amides as estrogen receptor ligands: synthesis, binding, activity and receptor interaction.
    Stauffer SR; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    Bioorg Med Chem; 2000 Jun; 8(6):1293-316. PubMed ID: 10896109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of selective estrogen receptor modulator (SERM)-like activity through an indirect mechanism of estrogen receptor antagonism: defining the binding mode of 7-oxabicyclo[2.2.1]hept-5-ene scaffold core ligands.
    Zheng Y; Zhu M; Srinivasan S; Nwachukwu JC; Cavett V; Min J; Carlson KE; Wang P; Dong C; Katzenellenbogen JA; Nettles KW; Zhou HB
    ChemMedChem; 2012 Jun; 7(6):1094-100. PubMed ID: 22517684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta.
    Sun J; Meyers MJ; Fink BE; Rajendran R; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 1999 Feb; 140(2):800-4. PubMed ID: 9927308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diaryl-dialkyl-substituted pyrazoles: regioselective synthesis and binding affinity for the estrogen receptor.
    Nishiguchi GA; Rodriguez AL; Katzenellenbogen JA
    Bioorg Med Chem Lett; 2002 Mar; 12(6):947-50. PubMed ID: 11959000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Halleux C; Kallen J; Keller H; Schlaeppi JM; Stark W
    J Med Chem; 2003 Jul; 46(14):2945-57. PubMed ID: 12825935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of estrogen receptor (ER) isoform messenger RNA expression by different ER ligands in female rat pituitary.
    Tena-Sempere M; Navarro VM; Mayen A; Bellido C; Sánchez-Criado JE
    Biol Reprod; 2004 Mar; 70(3):671-8. PubMed ID: 14613904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains.
    Zhou HB; Sheng S; Compton DR; Kim Y; Joachimiak A; Sharma S; Carlson KE; Katzenellenbogen BS; Nettles KW; Greene GL; Katzenellenbogen JA
    J Med Chem; 2007 Jan; 50(2):399-403. PubMed ID: 17228884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.
    Shim JY; Welsh WJ; Cartier E; Edwards JL; Howlett AC
    J Med Chem; 2002 Mar; 45(7):1447-59. PubMed ID: 11906286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the PROTAC degron candidates: OBHSA with different side chains as novel selective estrogen receptor degraders (SERDs).
    Li Y; Zhang S; Zhang J; Hu Z; Xiao Y; Huang J; Dong C; Huang S; Zhou HB
    Eur J Med Chem; 2019 Jun; 172():48-61. PubMed ID: 30939353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
    Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M; Caruso PL; Galbiati E; Lipreri M; Rivara S; Lodola A; Mor M
    Bioorg Med Chem; 2004 Jul; 12(14):3763-82. PubMed ID: 15210143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
    Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regioselective synthesis of 1,3,5-triaryl-4-alkylpyrazoles: novel ligands for the estrogen receptor.
    Huang YR; Katzenellenbogen JA
    Org Lett; 2000 Sep; 2(18):2833-6. PubMed ID: 10964377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular determinants of tissue selectivity in estrogen receptor modulators.
    Grese TA; Sluka JP; Bryant HU; Cullinan GJ; Glasebrook AL; Jones CD; Matsumoto K; Palkowitz AD; Sato M; Termine JD; Winter MA; Yang NN; Dodge JA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14105-10. PubMed ID: 9391160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based design and synthesis of conformationally constrained derivatives of methyl-piperidinopyrazole (MPP) with estrogen receptor (ER) antagonist activity.
    Ragab MA; Elagawany M; Daabees H; Ahmed AF; Awad EM; Billon C; Elgendy B; Abouzid KAM; Kassab SE
    Bioorg Chem; 2022 Feb; 119():105554. PubMed ID: 34923243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
    Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Amino-4,6-diarylpyridines as novel ligands for the estrogen receptor.
    Henke BR; Drewry DH; Jones SA; Stewart EL; Weaver SL; Wiethe RW
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1939-42. PubMed ID: 11459665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
    J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.